Nigeria and the United States Forge New Health Partnership Focused on Sovereignty and Domestic Financing

In a significant development for Nigeria's healthcare landscape, the nation has entered a new phase of collaboration with the United States, aimed at enhancing health services while prioritizing national sovereignty and domestic financing. This partnership, formalized through a Memorandum of Understanding (MoU) signed on December 19, 2025, is designed to transition from reliance on external funding to a more self-sufficient health system by 2030.

For over twenty years, Nigeria and the U.S. have collaborated on critical public health initiatives, including the President’s Emergency Plan for AIDS Relief (PEPFAR) and the President’s Malaria Initiative. These efforts have significantly improved health outcomes for millions of Nigerians. However, as the global funding landscape evolves, Nigeria recognizes the need to bolster its own health financing and institutional capabilities.

The MoU outlines a framework for a gradual shift in responsibility for health service financing and management. It stipulates that while the U.S. will provide nearly $2 billion in support over five years, Nigeria is expected to contribute approximately $3 billion from its own resources. This funding will be directed towards priority areas such as HIV, tuberculosis, malaria, and maternal and child health, ensuring that the financial resources remain within Nigeria and are aligned with national health priorities.

President Bola Ahmed Tinubu's administration has already begun to implement this vision, with a notable increase in the federal health budget. The 2025 budget saw a nearly 60% rise, elevating health expenditures to 5.2% of the national budget. The 2026 Appropriation Bill proposed an allocation of ₦2.48 trillion for health, reflecting a commitment to enhancing domestic investment in healthcare.

The MoU is legally non-binding and emphasizes the application of Nigerian law, allowing either party to withdraw from the agreement if necessary. This provision underscores Nigeria's commitment to maintaining control over its health policies and systems. The agreement also encourages public scrutiny, inviting citizens and civil society organizations to access the MoU under the Freedom of Information Act to foster informed discussions about its implications.

Key to the partnership is the recognition of Nigeria’s regulatory authority. The National Agency for Food and Drug Administration and Control (NAFDAC) will continue to oversee the safety and efficacy of medicines and vaccines, ensuring that Nigeria retains its decision-making power regarding health products.

Furthermore, the MoU includes provisions for supporting faith-based health providers, acknowledging their vital role in delivering healthcare, especially in underserved communities. This approach aims to enhance service delivery without favoring any particular religious group.

The success of this partnership will ultimately be measured by the improvements in health outcomes for Nigerians. The focus will be on maintaining treatment for people living with HIV, reducing deaths from malaria and tuberculosis, and ensuring better maternal and child health care. By 2030, the goal is for Nigeria to have a health system that is increasingly self-reliant and capable of sustaining improved health outcomes independently.

As Nigeria navigates this transition, the collaboration with the United States is expected to strengthen the foundations of its health system, ensuring that it can meet the needs of its population while reducing dependency on external assistance. The journey towards a more autonomous health sector is underway, with both nations committed to achieving shared health and development objectives.